LinkedIn Profile

Access Astex Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:astexpharmaceuticals-2 2867648 May 22nd, 2019 12:00AM Astex Pharmaceuticals (US) 5.0K 154.00 Open Pharmaceuticals May 22nd, 2019 10:38AM May 22nd, 2019 10:38AM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Open Oncology, Small-molecule therapeutics Open 4420 Rosewood Drive, Suite 200 Pleasanton CA US 94588 Pharmaceuticals & Biotechnology
private:astexpharmaceuticals-2 2867648 Feb 17th, 2018 12:00AM Astex Pharmaceuticals (US) 4.2K 154.00 Open Pharmaceuticals Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Pharmaceuticals & Biotechnology
private:astexpharmaceuticals-2 2867648 Feb 16th, 2018 12:00AM Astex Pharmaceuticals (US) 4.2K 154.00 Open Pharmaceuticals Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Pharmaceuticals & Biotechnology
private:astexpharmaceuticals-2 2867648 Feb 15th, 2018 12:00AM Astex Pharmaceuticals (US) 4.2K 154.00 Open Pharmaceuticals Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Pharmaceuticals & Biotechnology
private:astexpharmaceuticals-2 2867648 Feb 14th, 2018 12:00AM Astex Pharmaceuticals (US) 4.2K 154.00 Open Pharmaceuticals Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Pharmaceuticals & Biotechnology
private:astexpharmaceuticals-2 2867648 Feb 13th, 2018 12:00AM Astex Pharmaceuticals (US) 4.2K 154.00 Open Pharmaceuticals Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Pharmaceuticals & Biotechnology
private:astexpharmaceuticals-2 2867648 Feb 12th, 2018 12:00AM Astex Pharmaceuticals (US) 4.2K 154.00 Open Pharmaceuticals Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Pharmaceuticals & Biotechnology
private:astexpharmaceuticals-2 2867648 Feb 11th, 2018 12:00AM Astex Pharmaceuticals (US) 4.2K 154.00 Open Pharmaceuticals Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Pharmaceuticals & Biotechnology
private:astexpharmaceuticals-2 2867648 Feb 10th, 2018 12:00AM Astex Pharmaceuticals (US) 4.2K 154.00 Open Pharmaceuticals Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Pharmaceuticals & Biotechnology
private:astexpharmaceuticals-2 2867648 Feb 9th, 2018 12:00AM Astex Pharmaceuticals (US) 4.2K 154.00 Open Pharmaceuticals Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Astex Pharmaceuticals, please visit http://www.astx.com Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.